Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Non-diabetics
Serum TG \>150 mg/dL and \< or = 600 mg/dL
Serum LDL-C \>130 mg/dL
You may not be if
Type 1 or type 2 diabetics
Fasting plasma glucose \>126 mg/dL
Treatment with lipid-lowering drugs, unless they can be withdrawn within the following time frame prior to the first qualifying lipid determination (Week 2):
* Niacin or bile-acid binding agents and HMG CoA reductase inhibitors: 8 weeks
* Fibrates: 8 weeks
* Probucol: 1 year
History of active liver disease and/or history of thiazolidinedione-related (troglitazone, rosiglitazone, or pioglitazone) liver abnormalities, hepatic dysfunction, or jaundice
Clareo Health | Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia
